These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 24569695)

  • 1. Markers of inflammation and stress distinguish subsets of individuals with schizophrenia and bipolar disorder.
    Fillman SG; Sinclair D; Fung SJ; Webster MJ; Shannon Weickert C
    Transl Psychiatry; 2014 Feb; 4(2):e365. PubMed ID: 24569695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation and psychopathology: what we now know, and what we need to know.
    Uddin M; Diwadkar VA
    Soc Psychiatry Psychiatr Epidemiol; 2014 Oct; 49(10):1537-9. PubMed ID: 25073607
    [No Abstract]   [Full Text] [Related]  

  • 3. Inflammation-related transcripts define "high" and "low" subgroups of individuals with schizophrenia and bipolar disorder in the midbrain.
    Zhu Y; Owens SJ; Murphy CE; Ajulu K; Rothmond D; Purves-Tyson T; Middleton F; Webster MJ; Weickert CS
    Brain Behav Immun; 2022 Oct; 105():149-159. PubMed ID: 35764269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of inflammatory pathways in schizophrenia: A comparative study with bipolar disorder and healthy controls.
    García-Álvarez L; Caso JR; García-Portilla MP; de la Fuente-Tomás L; González-Blanco L; Sáiz Martínez P; Leza JC; Bobes J
    Eur Psychiatry; 2018 Jan; 47():50-59. PubMed ID: 29102659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between childhood trauma exposure and pro-inflammatory cytokines in schizophrenia and bipolar-I disorder.
    Quidé Y; Bortolasci CC; Spolding B; Kidnapillai S; Watkeys OJ; Cohen-Woods S; Berk M; Carr VJ; Walder K; Green MJ
    Psychol Med; 2019 Dec; 49(16):2736-2744. PubMed ID: 30560764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor.
    Hope S; Melle I; Aukrust P; Steen NE; Birkenaes AB; Lorentzen S; Agartz I; Ueland T; Andreassen OA
    Bipolar Disord; 2009 Nov; 11(7):726-34. PubMed ID: 19839997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus antibodies are associated with mood disorders, suicide, markers of neuroinflammation, and microglia activation in postmortem brain samples.
    Zheng H; Webster MJ; Weickert CS; Beasley CL; Paulus MP; Yolken RH; Savitz J
    Mol Psychiatry; 2023 Dec; 28(12):5282-5292. PubMed ID: 37391529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postmortem transcriptional profiling reveals widespread increase in inflammation in schizophrenia: a comparison of prefrontal cortex, striatum, and hippocampus among matched tetrads of controls with subjects diagnosed with schizophrenia, bipolar or major depressive disorder.
    Lanz TA; Reinhart V; Sheehan MJ; Rizzo SJS; Bove SE; James LC; Volfson D; Lewis DA; Kleiman RJ
    Transl Psychiatry; 2019 May; 9(1):151. PubMed ID: 31123247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innate immune response is differentially dysregulated between bipolar disease and schizophrenia.
    de Baumont A; Maschietto M; Lima L; Carraro DM; Olivieri EH; Fiorini A; Barreta LA; Palha JA; Belmonte-de-Abreu P; Moreira Filho CA; Brentani H
    Schizophr Res; 2015 Feb; 161(2-3):215-21. PubMed ID: 25487697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multianalyte markers of schizophrenia and bipolar disorder: A preliminary study.
    Dickerson F; Schroeder J; Stallings C; Origoni A; Bahn S; Yolken R
    Schizophr Res; 2015 Oct; 168(1-2):450-5. PubMed ID: 26298538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disrupted glucocorticoid--Immune interactions during stress response in schizophrenia.
    Chiappelli J; Shi Q; Kodi P; Savransky A; Kochunov P; Rowland LM; Nugent KL; Hong LE
    Psychoneuroendocrinology; 2016 Jan; 63():86-93. PubMed ID: 26431803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiology of schizophrenia, bipolar disorder, and schizoaffective disorder.
    Martin LF; Hall MH; Ross RG; Zerbe G; Freedman R; Olincy A
    Am J Psychiatry; 2007 Dec; 164(12):1900-6. PubMed ID: 18056246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of immunological factors in the pathophysiology and diagnosis of bipolar disorder: comparison with schizophrenia.
    Altamura AC; Buoli M; Pozzoli S
    Psychiatry Clin Neurosci; 2014 Jan; 68(1):21-36. PubMed ID: 24102953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of IL-6, IL-10 and TNF-α in patients with bipolar disorder and schizophrenia: differences in pro- and anti-inflammatory balance.
    Kunz M; Ceresér KM; Goi PD; Fries GR; Teixeira AL; Fernandes BS; Belmonte-de-Abreu PS; Kauer-Sant'Anna M; Kapczinski F; Gama CS
    Braz J Psychiatry; 2011 Sep; 33(3):268-74. PubMed ID: 21971780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The microbiome, immunity, and schizophrenia and bipolar disorder.
    Dickerson F; Severance E; Yolken R
    Brain Behav Immun; 2017 May; 62():46-52. PubMed ID: 28003152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gray matter volume as an intermediate phenotype for psychosis: Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP).
    Ivleva EI; Bidesi AS; Keshavan MS; Pearlson GD; Meda SA; Dodig D; Moates AF; Lu H; Francis AN; Tandon N; Schretlen DJ; Sweeney JA; Clementz BA; Tamminga CA
    Am J Psychiatry; 2013 Nov; 170(11):1285-96. PubMed ID: 24185241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of the association between N-methyl-d-aspartate receptor antibodies and schizophrenia, schizoaffective disorder, bipolar disorder, and major depressive disorder.
    Pearlman DM; Najjar S
    Schizophr Res; 2014 Aug; 157(1-3):249-58. PubMed ID: 24882425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation at the DAOA/G30 locus influences susceptibility to major mood episodes but not psychosis in schizophrenia and bipolar disorder.
    Williams NM; Green EK; Macgregor S; Dwyer S; Norton N; Williams H; Raybould R; Grozeva D; Hamshere M; Zammit S; Jones L; Cardno A; Kirov G; Jones I; O'Donovan MC; Owen MJ; Craddock N
    Arch Gen Psychiatry; 2006 Apr; 63(4):366-73. PubMed ID: 16585465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Schizophrenia and bipolar disorder show both common and distinct changes in cortical interneuron markers.
    Fung SJ; Fillman SG; Webster MJ; Shannon Weickert C
    Schizophr Res; 2014 May; 155(1-3):26-30. PubMed ID: 24674775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The distribution and morphology of prefrontal cortex pyramidal neurons identified using anti-neurofilament antibodies SMI32, N200 and FNP7. Normative data and a comparison in subjects with schizophrenia, bipolar disorder or major depression.
    Law AJ; Harrison PJ
    J Psychiatr Res; 2003; 37(6):487-99. PubMed ID: 14563380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.